Randal W. Scott, CEO, In Vitae Corporation* at GENOMIC HEALTH INC (GHDX), sold 30,000 shares at $34.56 ($1.0M) on 2012-06-11, disclosed to the SEC on 2012-06-13.
Scheduled sale ($1.0M) by CEO, In Vitae Corporation* under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.74 | 14,400 | $486K | 48.3% |
| 2 | $34.56 | 600 | $21K | 2.1% |
| 3 | $33.31 | 15,000 | $500K | 49.7% |
| Total | $33.54 avg | 30,000 | $1.0M | 100% |
| Filing → |
| NVTA | SELL | 2019-02-27 | $573K | — | Filing → |
| NVTA | BUY | 2018-04-02 | $200K | — | Filing → |
| NVTA | BUY | 2016-11-22 | $400K | — | Filing → |